Skip to main content

Table 1 Patient and tumor characteristics

From: The ability of whole-body SUVmax in F-18 FDG PET/CT to predict suboptimal cytoreduction during primary debulking surgery for advanced ovarian cancer

Variable

Median (range) or Number (%)

Age (years)

58.0 (37–74)

FIGO stage

 IIIC

37 (72.5)

 IV

14 (27.5)

Tumor grade

 1

1 (2.0)

 2

8 (15.7)

 3

42 (82.4)

Histology

 Serous

40 (78.4)

 Endometroid

5 (9.8)

 Clear

2 (3.9)

 Mucinous

1 (2.0)

 Others

3 (5.9)

Preoperative CA 125 (U/mL)

573.7 (38–6000)

Ascites

  < 500 mL

11 (21.6)

  >  500 mL

40 (78.4)

ECOG PS

 0

8 (15.7)

 1

31 (60.8)

 2

12 (23.6)

  1. FIGO International Federation of Gynecology and Obstetrics, ECOG PS Eastern cooperative oncology group performance status